Oxford Biomedica and Homology Medicines to form new company

830
1
Oxford Biomedica plc, a leading gene and cell therapy group, and Homology Medicines Inc., a genetic medicines company, Jan. 28 signed agreement to establish a high-performing, full scope Oxford Biomedica Solutions LLC (Adeno-Associated Virus (AAV) Manufacturing and Innovation Business) in the US

You need to subscribe for access to restricted content.

Sign up
Login:
Password:
Forgot your password?